Company Information
Developing revolutionary ophthalmic therapeutics through biomaterial innovations, Pleryon is a pharmaceutical company. Proprietary biomaterial design technology addresses the significant unmet medical needs in ophthalmology, allowing previously undruggable compounds to be developed as ophthalmic therapeutics.
The leading products in our pipeline include a contact lens lubricant, dry-eye veterinary therapeutics, and a long-acting anti-VEGF therapeutic for age-related macular degeneration.
Pleryon is a spin-off from the Laboratory of Drug Delivery and Biomaterials of HKUST, cofounded by Prof. Ying Chau, Director of HKUST’s Bioengineering Program and Vice President of Hong Kong biotech Association, and Dr. Yu Yu, an award-winning biomaterial inventor and entrepreneur.
Website
Address
HKUST SRI Building, Yuexing 1 Road, Nanshan, Shenzhen, P. R. China